<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Boehringer launches first licensed treatment for Equine Cushing's Disease</title><link>/b/veterinary-nursing-news/posts/98558</link><description>Boehringer
Ingelheim Vetmedica has launched Prascend,
the first licensed product for the treatment of Pituitary Pars Intermedia
Dysfunction (PPID) in horses, commonly known as Equine Cushing&amp;#39;s Disease. 
 Prascend
contains pergolide mesylate,...</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>